Model Number D134805 |
Device Problem
Patient Device Interaction Problem (4001)
|
Patient Problems
Cardiac Tamponade (2226); Unspecified Tissue Injury (4559)
|
Event Date 03/28/2023 |
Event Type
Injury
|
Manufacturer Narrative
|
This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc.Or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|
|
Event Description
|
It was reported that a patient underwent an atrial fibrillation (afib)ablation procedure with a thermocool® smart touch® sf bi-directional navigation catheter.The patient suffered cardiac tamponade and a soft tissue injury requiring surgical intervention.It was reported that during the procedure, the ablation firing having already started, a tamponade was discovered.Surgical treatment necessary.Wound found on the ridge (under the left pulmonary veins).Ablation catheter used with the smartablate generator, in power control mode, at 50w.Additional information- physician¿s opinion on the cause of this adverse event was the procedure.Intervention provided was sternotomy and surgical repair of the puncture.Patient required extended hospitalization because of the adverse event to recover from the surgery.Smartablate g4c-4948 was used.Transseptal puncture was performed.Prior to noting the pe or ct, ablation was performed.No evidence of steam pop.Irrigated catheter was used in the event, the flow setting was 2/8/15 ml/min.Correct catheter settings were selected on the generator.Pump switching was from ¿low¿ to ¿high¿ flow during ablation.No error messages observed on biosense webster equipment during the procedure.All force visualization features were used.Visitag module was used, parameters for stability used were 3mm, 3sec, 3g 25%.Tag size 3.Additional filter used with the visitag was ablation index : 400 pst 450 ant.Ablation index was used.Since the event is life threatening and it might result in permanent impairment of a body function or permanent damage to a body structure; or it could require medical or surgical intervention to prevent permanent impairment of a body function or permanent damage to a body structure, it is to be considered serious.
|
|
Manufacturer Narrative
|
On 3-may-2023, the bwi product analysis lab received the device for evaluation.The product investigation was subsequently completed.It was reported that a patient underwent an atrial fibrillation (afib)ablation procedure with a thermocool® smart touch® sf bi-directional navigation catheter.The patient suffered cardiac tamponade and a soft tissue injury requiring surgical intervention.It was reported that during the procedure, the ablation firing having already started, a tamponade was discovered.Surgical treatment necessary.Wound found on the ridge (under the left pulmonary veins).Ablation catheter used with the smartablate generator, in power control mode, at 50w.Device evaluation details: visual analysis revealed no damage or anomalies on the device.The device features were reviewed, and no issues were observed during the product investigation.A manufacturing record evaluation was performed for the finished device 30940209l number, and no internal actions related to the reported complaint condition were identified.No malfunction was observed during the product analysis.The root cause of the adverse event remains unknown.The physician¿s opinion on the cause of this adverse event was the procedure.In addition, no device malfunction was reported, there may have been other circumstances or issues that occurred during the use of the device that could not be replicated during the analysis.The instruction for use (ifu) states that careful catheter manipulation must be performed to avoid cardiac damage, perforation, or tamponade.As part of biosense webster¿s quality process, all devices are manufactured, inspected, and released to approved specifications.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|
|
Search Alerts/Recalls
|
|